source
- Novo Nordisk vows to launch five multi-blockbuster drugs by 2030 as it shifts toward consumer-style productsNovo Nordisk used its London capital markets day to reassure investors that the company will broaden its pipeline and market new medicines more like consumer products than traditional drugs. The C…
- Telix to acquire Germany's ITM for $1.65 billion, aiming to dominate radiopharmaceutical marketTelix, an Australian radiopharmaceutical diagnostics company, announced it will purchase German developer ITM in a cash transaction valued at $1.65 billion upfront. The agreement gives Telix the o…